| MR编号 | CZ/V/0129/001 |
|---|
| 药品名称 | BOVALTO Respi 4 |
|---|
| 活性成分 | - Bovine parainfluenza 3 virus inactivated 1.0 RP
- bovine respiratory syncytial virus inactivated 1.0 RP
- bovine viral diarrhoea virus inactivated 1.0 RP
- Pasteurella Haemolytica A1 inactivated 1.0 RP
|
|---|
| 剂型 | Suspension for injection |
|---|
| 上市许可持有人 | Boehringer Ingelheim Animal Health France SCS - 29 avenue Tony Garnier, 69007 Lyon - FRANCE |
|---|
| 参考成员国 - 产品名称 | Czechia (CZ) BOVALTO Respi 4 injekční suspenze |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
- Belgium (BE)
Bovalto Respi 4 - Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Poland (PL)
- Romania (RO)
- Netherlands (NL)
|
|---|
| 许可日期 | 2015/10/21 |
|---|
| 最近更新日期 | 2023/07/08 |
|---|
| 药物ATC编码 | - QI02AL04 bovine parainfluenza virus + bovine respiratory syncytial virus + pasteurella
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|